AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 207 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,472,000 | +70.2% | 185,963 | +19.9% | 0.01% | +40.0% |
Q3 2016 | $3,803,000 | +3.6% | 155,151 | +1.1% | 0.01% | 0.0% |
Q2 2016 | $3,671,000 | +15.0% | 153,490 | +12.5% | 0.01% | +25.0% |
Q1 2016 | $3,191,000 | +6.6% | 136,377 | +37.5% | 0.00% | 0.0% |
Q4 2015 | $2,993,000 | +27.4% | 99,155 | +67.6% | 0.00% | +33.3% |
Q3 2015 | $2,350,000 | -42.5% | 59,159 | 0.0% | 0.00% | -40.0% |
Q2 2015 | $4,086,000 | +14.7% | 59,159 | -9.2% | 0.01% | 0.0% |
Q1 2015 | $3,562,000 | +26.2% | 65,168 | -1.6% | 0.01% | +25.0% |
Q4 2014 | $2,823,000 | +31.7% | 66,237 | -1.4% | 0.00% | +33.3% |
Q3 2014 | $2,144,000 | +55.5% | 67,178 | +0.9% | 0.00% | +50.0% |
Q2 2014 | $1,379,000 | +19.1% | 66,573 | +11.3% | 0.00% | 0.0% |
Q1 2014 | $1,158,000 | -19.5% | 59,835 | +1.0% | 0.00% | 0.0% |
Q4 2013 | $1,438,000 | +9.7% | 59,223 | -3.0% | 0.00% | 0.0% |
Q3 2013 | $1,311,000 | +2.2% | 61,045 | +5.9% | 0.00% | 0.0% |
Q2 2013 | $1,283,000 | – | 57,651 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |